Literature DB >> 453331

Canine granulocytopathy syndrome: an inherited disorder of leukocyte function.

H W Renshaw, W C Davis.   

Abstract

A disease closely resembling the human neutrophil dysfunction syndromes has been identified in a colony of dogs. The syndrome, referred to as the canine granulocytopathy syndrome, is characterized by recurrent-life-threatening bacterial infections and a greatly shortened life span. The disease is genetically determined, being transmitted as an autosomal recessive trait. The increased susceptibity to pyogenic infections and shortened life span is related to an impairment of leukocyte function at the cellular level. Preparation of neutrophils from affected animals exhibit impaired in vitro killing of Esherichia coli. The defect in bactericidal activity is associated with reduced glucose oxidation by the hexose monophosphate shunt and an increase capacity to reduce nitroblue tetrazolium dye. The data obtained thus far indicate the canine granulocytopathy syndrome will be of considerable value as a model for study of granulocytypathy sydromes in man.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 453331      PMCID: PMC2042304     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  48 in total

1.  Pathology of bactericidal power of neutrophils.

Authors:  P G Quie
Journal:  Semin Hematol       Date:  1975-04       Impact factor: 3.851

2.  The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes.

Authors:  R B Johnston; B B Keele; H P Misra; J E Lehmeyer; L S Webb; R L Baehner; K V RaJagopalan
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

3.  Oxygen-dependent microbial killing by phagocytes (second of two parts).

Authors:  B M Babior
Journal:  N Engl J Med       Date:  1978-03-30       Impact factor: 91.245

4.  The biochemical basis of nitroblue tetrazolium reduction in normal human and chronic granulomatous disease polymorphonuclear leukocytes.

Authors:  R L Baehner; L A Boxer; J Davis
Journal:  Blood       Date:  1976-08       Impact factor: 22.113

Review 5.  Molecular events during phagocytosis by human neutrophils.

Authors:  P G Quie; E L Mills; B Holmes
Journal:  Prog Hematol       Date:  1977

6.  Neutrophil dysfunction, chronic granulomatous disease, and non-spherocytic haemolytic anaemia caused by complete deficiency of glucose-6-phosphate dehydrogenase.

Authors:  G R Gray; G Stamatoyannopoulos; S C Naiman; M R Kliman; S J Klebanoff; T Austin; A Yoshida; G C Robinson
Journal:  Lancet       Date:  1973-09-08       Impact factor: 79.321

7.  An anomaly of neutrophil morphology with impaired function.

Authors:  R G Strauss; K E Bove; J F Jones; A M Mauer; V A Fulginiti
Journal:  N Engl J Med       Date:  1974-02-28       Impact factor: 91.245

Review 8.  Primary immunodeficiencies. Report of a World Health Organization Committee.

Authors:  H Fudenberg; R A Good; H C Goodman; W Hitzig; H G Kunkel; I M Roitt; F S Rosen; D S Rowe; M Seligmann; J R Soothill
Journal:  Pediatrics       Date:  1971-05       Impact factor: 7.124

9.  Canine granulocytopathy syndrome: neutrophil dysfunction in a dog with recurrent infections.

Authors:  H W Renshaw; C Chatburn; G M Bryan; R C Bartsch; W C Davis
Journal:  J Am Vet Med Assoc       Date:  1975-03-01       Impact factor: 1.936

10.  Canine granulocytopathy syndrome: defective bactericidal capacity of neutrophils from a dog with recurrent infections.

Authors:  H W Renshaw; W C Davis; S J Renshaw
Journal:  Clin Immunol Immunopathol       Date:  1977-11
View more
  2 in total

1.  Feline leukocyte adhesion (CD18) deficiency caused by a deletion in the integrin β2 (ITGB2) gene.

Authors:  Thomas R Bauer; Suzanne M Pratt; Christina M Palena; Karthik Raj; Urs Giger
Journal:  Vet Clin Pathol       Date:  2017-07-27       Impact factor: 1.180

2.  Bovine leukocyte adhesion deficiency. Beta 2 integrin deficiency in young Holstein cattle.

Authors:  M E Kehrli; M R Ackermann; D E Shuster; M J van der Maaten; F C Schmalstieg; D C Anderson; B J Hughes
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.